TY - GEN
T1 - Techno-economic Analysis of Indonesian Antineurodegenerative Mixed-Herb Extract Manufacturing Plant
AU - Tristantini, Dewi
AU - Lazuardi, David
AU - Santoso, Leon Lukhas
N1 - Funding Information:
The authors thank all research staff, lecturers, and academic staff in the Department of Chemical Engineering, Universitas Indonesia, for providing the necessary facilities to carry out this study. The authors also thank Millennie Fitria from the Department of Chemical Engineering Universitas Indonesia for her help writing the manuscript. This research is partially funded by the Applied Research BRIN Program (NKB-252/UN2.RST/HKP.05.00/2021), managed by the Directorate of Research and Development Universitas Indonesia.
Publisher Copyright:
© 2022 American Institute of Physics Inc.. All rights reserved.
PY - 2022/8/16
Y1 - 2022/8/16
N2 - Neuropathic pain is a form of chronic pain with a prevalence ranging from 7-10% of the population in developed countries. The most commonly used pharmaceutical drug in the treatment of neuropathic pain is an antidepressant. Some herbs such as nutmeg (Myristica fragrans), cloves (Syzygium aromaticum), and ginger (Zingiber officinale) empirically can be used as herbal medicine to reduce nerve tension with lower side effects. The ingredients that have been obtained will be extracted to get herbal extracts, then produced to get herbal drinks that can easily be consumed by most of the consumers. This study examines the techno-economic analysis of a healthy herbal drink that provides the cure for pain and can also address people who love healthy drinks. The formulation of the herbal drinks consists of cloves, nutmeg, and ginger. The manufacturing process consists of the extraction of cloves, nutmeg, and ginger in hot water and then filtration before being sealed in a bottle. The plant design will produce 4, 133 bottles per day with a price of Rp 15, 000 for each bottle. The capital investment of our plant is Rp 10, 821, 420, 278, with an IRR as high as 122.06%. Our NPV is Rp 113, 277, 031, 973 with payback period of 1.14 years. Our product is relatively sensitive to the selling price and the price of the raw materials.
AB - Neuropathic pain is a form of chronic pain with a prevalence ranging from 7-10% of the population in developed countries. The most commonly used pharmaceutical drug in the treatment of neuropathic pain is an antidepressant. Some herbs such as nutmeg (Myristica fragrans), cloves (Syzygium aromaticum), and ginger (Zingiber officinale) empirically can be used as herbal medicine to reduce nerve tension with lower side effects. The ingredients that have been obtained will be extracted to get herbal extracts, then produced to get herbal drinks that can easily be consumed by most of the consumers. This study examines the techno-economic analysis of a healthy herbal drink that provides the cure for pain and can also address people who love healthy drinks. The formulation of the herbal drinks consists of cloves, nutmeg, and ginger. The manufacturing process consists of the extraction of cloves, nutmeg, and ginger in hot water and then filtration before being sealed in a bottle. The plant design will produce 4, 133 bottles per day with a price of Rp 15, 000 for each bottle. The capital investment of our plant is Rp 10, 821, 420, 278, with an IRR as high as 122.06%. Our NPV is Rp 113, 277, 031, 973 with payback period of 1.14 years. Our product is relatively sensitive to the selling price and the price of the raw materials.
KW - cloves
KW - ginger
KW - herbal medicine
KW - nutmeg
KW - plant
KW - viability
UR - http://www.scopus.com/inward/record.url?scp=85138263006&partnerID=8YFLogxK
U2 - 10.1063/5.0097887
DO - 10.1063/5.0097887
M3 - Conference contribution
AN - SCOPUS:85138263006
T3 - AIP Conference Proceedings
BT - 6th Biomedical Engineering''s Recent Progress in Biomaterials, Drugs Development, and Medical Devices
A2 - Rahman, Siti Fauziyah
A2 - Zakiyuddin, Ahmad
A2 - Whulanza, Yudan
A2 - Intan, Nurul
PB - American Institute of Physics Inc.
T2 - 6th International Symposium of Biomedical Engineering''s Recent Progress in Biomaterials, Drugs Development, and Medical Devices, ISBE 2021
Y2 - 7 July 2021 through 8 July 2021
ER -